Medical Professionals

our clinical trials

bluebird bio is conducting clinical studies of investigational gene therapies in four diseases: transfusion-dependent β-thalassemia, severe sickle cell disease, cerebral adrenoleukodystrophy, and relapsed/refractory multiple myeloma.

For more information, follow the links below to the study listings on clinicaltrials.gov. Medical professionals may also email us at clinicaltrials@bluebirdbio.com for more information about study participation.

 

Learn more about our ongoing clinical trials: